Concepedia

Stephanie de Bono

SD

32

Publications

6.1K

Citations

22

H-Index

2001

Active since

Affiliations

Eli Lilly (United States)(Current)

University of Occupational and Environmental Health Japan

NIHR Leeds Musculoskeletal Biomedical Research Unit

University of Leeds

Hôpital Cochin

Stephanie de Bono is an author at Eli Lilly (United States) specializing in medicine, clinical trials, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2001–2022

32

Publications

32

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

Peter C. Taylor, Edward Keystone, Désirée van der Heijde et al. · New England Journal of Medicine · 2017 · 895 citations · Full text

Baricitinib in Patients with Refractory Rheumatoid Arthritis

Mark C. Genovese, Joel Kremer, Omid Zamani et al. · New England Journal of Medicine · 2016 · 598 citations · Full text

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

Daniel J. Wallace, Richard Furie, Yoshiya Tanaka et al. · The Lancet · 2018 · 497 citations · Full text

, , +8

Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment

Roy Fleischmann, Michael Schiff, Désirée van der Heijde et al. · Arthritis & Rheumatology · 2016 · 396 citations · Full text

Rows per page

1–5 of 32